下肢黑色素瘤Mohs术前前哨淋巴结活检省略蓝染的疗效
研究评估下肢黑色素瘤患者在Mohs显微描记手术(MMS)前接受前哨淋巴结活检(SLNB)时省略蓝染注射的可行性。结论为省略蓝染不影响SLNB准确性,且对MMS有显著优势。
要点
- 下肢黑色素瘤MMS术前SLNB省略蓝染注射不影响诊断准确性。
- 省略蓝染可避免病理误判和临床边界模糊,利于MMS手术。
- 该研究中SLNB成功率为98%,5年总生存率78%、无病生存率76%。
核心结论
- 省略蓝染注射不损害标准前哨淋巴结活检的准确性,且对黑色素瘤Mohs显微描记手术有明显优势。
研究设计与样本
- 回顾性评估2010至2016年间接受MMS(伴或不伴SLNB)的下肢黑色素瘤患者,术前用淋巴闪烁显像定位原发灶、术中用伽马探头确认。
主要发现
- 5年总生存率为78%,5年无病生存率为76%。
临床怎么用
- 下肢黑色素瘤患者在MMS术前可考虑省略蓝染注射行SLNB,以避免蓝染导致的病理误判和边界模糊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sentinel lymph node biopsy (SLNB) is usually performed using a triple technique that includes lymphoscintigraphy (LSG), which involves the injection of a radiolabelled tracer, blue dye injection, and detection of the radioisotope with a gamma probe. However, blue dye injection may cause pathological misinterpretation and obscure clinical margins, especially when combined with Mohs micrographic surgery (MMS) for cutaneous melanoma. OBJECTIVES: To assess the efficacy of SLNB without blue dye injection in patients who subsequently underwent MMS for melanomas of the lower extremities. METHODS: We evaluated patients who underwent MMS with or without SLNB using preoperative localization of the primary melanoma via LSG and intraoperative confirmation using a gamma probe between 2010 and 2016. RESULTS: Seventy-two patients with melanoma of mean Breslow thickness 3·03 ± 1·44 mm were evaluated. Sixty-five of the 72 patients underwent SLNB, the success rate of which was 98%. The 5-year overall and disease-free survival rates were 78% and 76%, respectively. CONCLUSIONS: Blue dye injection can be omitted without compromising the accuracy of standard SLNB. Omitting blue dye injection also has marked advantages in MMS for melanoma. What's already known about this topic? Sentinel lymph node biopsy (SLNB) is usually performed using a triple technique including lymphoscintigraphy, which involves the injection of a radiolabelled tracer, blue dye injection, and radioisotope detection using a gamma probe. Blue dye injection may cause pathological misinterpretation and obscure clinical margins. What does this study add? Omitting the dye does not decrease diagnostic accuracy and is particularly advantageous for Mohs micrographic surgery (MMS) in melanomas with clinically indistinct tumour borders. SLNB without blue dye injection is feasible in MMS for melanoma.
引用
- Kim TH, Kim HJ, Seo JW, et al. Efficacy and clinical significance of omitting blue dye injection during sentinel lymph node biopsy before Mohs micrographic surgery for malignant melanoma of the lower extremities. Br J Dermatol. 2019. PMID: 31077333. doi:10.1111/bjd.18121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。